Migraine's 'Silver Lining': Lowered Risk for Diabetes?

MONDAY, Dec. 17, 2018 -- A study of more than 74,000 French women has turned up an unexpected finding: Those who suffer from migraines have a significantly lower risk for type 2 diabetes.

The finding is based on surveys sent to thousands of women born between 1925 and 1950. The study found that -- after adjusting for body weight and other health factors -- women who said they had migraines had a 30 percent lower risk of type 2 diabetes, the leading form of the blood sugar disease.

People With Movement Disorders May Become Immune to Botox Therapy

FRIDAY, Dec. 28, 2018 -- Some people who receive botulinum toxin injections for disorders that cause muscle tightness and contractions develop resistance to the treatment, researchers say.

The new study included nearly 600 patients with dystonia or spasticity who had been receiving botulinum toxin type A (commonly known as "Botox") for about three to five years.

Sudden Death Risk in Epilepsy Can Wane Over Time

SUNDAY, Dec. 2, 2018 -- The risk of sudden unexpected death in people with epilepsy can change over time, and it usually changes for the better, a new study reports.

In what the researchers are calling hopeful news, the study found that people who have a medium or high risk of sudden unexpected death in epilepsy (SUDEP) often don't remain at the same risk level.

Benefits of CBD Liquid for Epilepsy May Fade With Time: Study

SUNDAY, Dec. 2, 2018 -- A marijuana-derived drug that helps control epileptic seizures appears to become less effective over time in some patients, a new Israeli study reports.

Cannabidiol (CBD) liquid has been proven effective against seizures, but about one-third of patients develop tolerance that blunts the drug's effectiveness, according to research presented Sunday at the American Epilepsy Society's annual meeting, in New Orleans.